• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH¿ BI-DIRECTIONAL NAVIGATION CATHETER; SIMILAR DEVICE D132701, PMA # P030031/S053

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC THERMOCOOL® SMART TOUCH¿ BI-DIRECTIONAL NAVIGATION CATHETER; SIMILAR DEVICE D132701, PMA # P030031/S053 Back to Search Results
Catalog Number UNK_SMART TOUCH BIDIRECTIONAL
Device Problem Patient Device Interaction Problem (4001)
Patient Problems Transient Ischemic Attack (2109); Cardiac Tamponade (2226); Vascular Dissection (3160); Heart Block (4444)
Event Date 03/25/2022
Event Type  Injury  
Event Description
This complaint is from a literature source.The following literature cite has been reviewed: rexha e, heeger ch, maack s, rottner l, wohlmuth p, lemes c, maurer t, reissmann b, rillig a, mathew s, sohns c, ouyang f, kuck kh, metzner a.Impact of a time-to-effect-guided ablation protocol in cryoballoon ablation on the durability of pulmonary vein isolation.J cardiovasc electrophysiol.2022 jun;33(6):1096-1103.Doi: 10.1111/jce.15453.Epub 2022 mar 25.Pmid: (b)(6).Objective/methods/study data: background: cryoballoon (cb)-based pulmonary vein isolation (pvi) has proven to be as effective as radiofrequency-based ablation.Different ablation protocols took the individual time-to-isolation (tti) into account aiming at shorter but equally or even more effective freeze cycles.The current study sought to assess the impact of the tti on pvi durability in patients undergoing a repeat procedure for recurrence of atrial tachyarrhythmia (ata).Methods and results: in 205 patients with ata recurrence after previous cb-based pvi, a total of 806 pulmonary veins (pvs) were identified.A total of 126 out of 806 pvs (16%) were previously treated with a tti-guided ablation (protocol #1; tti + 120 s), in 92/806 (11%) pvs tti was only monitored (m) but fixed freeze cycles were applied (protocol #2; mtti) and in 588/806 (73%) a fixed freeze cycle was applied without mtti.There was no difference in the pv-reconduction rate between the groups (p =.23).The right inferior pulmonary vein (ripv) showed overall significantly higher reconduction rates compared to the other pvs (ripv¿left inferior pv p <.003, ¿left superior pv p <.001, ¿right superior pv p <.013).Twenty-one patients (10%) were demonstrated to have only electrical reconduction of the ripv, while all other pvs were still electrically isolated.-conclusions: the tti-based cb ablation protocol did not show significant differences regarding pv-reconduction rates compared to the other ablation protocols.Lot, model and catalog number are not available, but the suspected biosense device possibly associated with reported adverse events: -thermocool®; biosense webster inc.Other biosense webster concomitant devices that were also used in this study: -carto; biosense webster inc.-lassotm; biosensewebster non-biosense webster devices that were also used in this study: -achieve catheter; medtronic inc.Adverse event(s) and provided interventions: complications were documented in 8 patients that could be associated with bwi devices: 4 pericardial tamponade which occurred in pericardiocentesis was performed in all four patients no surgery was required.1 patient had a transient ischemic attack.1 transient sinus arrest (heart block).1 transient av-block iii° (heart block av ).1 dissection of the coronary sinus (vascular dissection).No additional information was provided regarding intervention or outcomes.
 
Manufacturer Narrative
Manufacturer's ref no: (b)(4).This complaint is from a literature source.The following literature cite has been reviewed: rexha e, heeger ch, maack s, rottner l, wohlmuth p, lemes c, maurer t, reissmann b, rillig a, mathew s, sohns c, ouyang f, kuck kh, metzner a.Impact of a time-to-effect-guided ablation protocol in cryoballoon ablation on the durability of pulmonary vein isolation.J cardiovasc electrophysiol.2022 jun;33(6):1096-1103.Doi: 10.1111/jce.15453.Epub 2022 mar 25.Pmid: (b)(6).Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.Manufacturing record evaluation (mre) cannot be conducted because no lot number was not provided by the customer.This report is being submitted pursuant to the provisions of 21 cfr, part 4.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster inc., or its employees that the report constitutes an admission that the product, biosense webster inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMOCOOL® SMART TOUCH¿ BI-DIRECTIONAL NAVIGATION CATHETER
Type of Device
SIMILAR DEVICE D132701, PMA # P030031/S053
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
michelleann garcia
31 technology dr
irvine, CA 92618
646591-798
MDR Report Key15325631
MDR Text Key298950315
Report Number2029046-2022-02049
Device Sequence Number1
Product Code LPB
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
P030031/S053
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Literature,Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 08/30/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK_SMART TOUCH BIDIRECTIONAL
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/03/2022
Initial Date FDA Received08/31/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
AGILIS EPI ABBOTT, ST PAUL; CARTO-3 SYSTEM; ENSITE VELOCITY NAVIGATION SYSTEM; LONG SHEATH (AGILIS-L ABBOTT, ST PAUL, MN, US); THERAPY¿ COOL FLEX¿ ABLATION CATHETER, ABBOTT,
Patient Outcome(s) Required Intervention; Life Threatening;
-
-